Compounds > testolactone
Page last updated: 2024-08-21

testolactone and Abdominal Neoplasms

testolactone has been researched along with Abdominal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BISEL, HF1
Waddell, WR1
Kirsch, WM; Waddell, WR1

Other Studies

3 other study(ies) available for testolactone and Abdominal Neoplasms

ArticleYear
TREATMENT OF ADVANCED BREAST CARCINOMA WITH DELTA 1-TESTOLOLACTONE.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Abdominal Neoplasms; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Humans; Neoplasm Metastasis; Neoplasms; Testolactone

1964
Treatment of intra-abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3',5'-adenosine monophosphate.
    Annals of surgery, 1975, Volume: 181, Issue:3

    Topics: Abdominal Muscles; Abdominal Neoplasms; Adult; Bone Neoplasms; Cyclic AMP; Female; Fibroma; Humans; Intestinal Polyps; Neoplasms, Multiple Primary; Odontogenic Tumors; Osteoma; Pelvic Neoplasms; Phosphodiesterase Inhibitors; Skin Neoplasms; Syndrome; Testolactone; Time Factors

1975
Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors.
    American journal of surgery, 1991, Volume: 161, Issue:4

    Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibroma; Gardner Syndrome; Humans; Indomethacin; Male; Remission Induction; Sulindac; Tamoxifen; Testolactone; Time Factors; Vitamin K 1; Warfarin

1991